Vanda Pharmaceuticals Inc. — Director's Dealing 2010

Feb 23, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2010-02-19

Reporting Person: Irish Stephanie Rast (Acting CFO/Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-19	Common Stock	S	20000	$10.59	Disposed	2249	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $10.56 to $10.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.